Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Naturally Acquired SARS-CoV-2 Immunity Persists for Up to 11 Months Following Infection
Valeria De Giorgi, Kamille A. West, Amanda N. Henning, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 8, pp. 1294-1304
Open Access | Times Cited: 58

Showing 26-50 of 58 citing articles:

SARS-CoV-2 Antibody Kinetics in Unvaccinated Hospitalized Children With COVID-19
Dimitra Dimopoulou, Marietta Charakida, Antonios Marmarinos, et al.
The Pediatric Infectious Disease Journal (2024) Vol. 43, Iss. 6, pp. 536-542
Closed Access | Times Cited: 1
System for classifying antibody concentration against severe acute respiratory syndrome coronavirus 2 S1 spike antigen with automatic quick response generation for integration with health passports
Apostolos Apostolakis, Dimitris Barmpakos, Sophie Mavrikou, et al.
(2024), pp. 20-29
Open Access | Times Cited: 1
Association between clinical symptoms during the COVID‐19 infection and SARS‐CoV‐2 immunoglobulin G titers in COVID‐19 convalescent whole‐blood donors in China
Xue Chen, Humin Liu, Meng Li, et al.
Transfusion (2024) Vol. 64, Iss. 6, pp. 1025-1039
Closed Access | Times Cited: 1
Quantity of IgG response to SARS-CoV-2 spike glycoprotein predicts pulmonary recovery from COVID-19
Manfred Nairz, Sabina Sahanic, Alex Pizzini, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 5
COVID-19 vaccination and booster induced authentic-virus neutralizing antibody response is superior to SARS-CoV-2 natural infection induced response
Lauren L. Ching, Alanna C. Tseng, Eileen Nakano, et al.
Journal of Clinical Virology (2022) Vol. 152, pp. 105185-105185
Open Access | Times Cited: 5
Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients
O. Bylicki, D. Delarbre, Aurélie Mayet, et al.
International Journal of Infectious Diseases (2021) Vol. 112, pp. 8-12
Open Access | Times Cited: 6
COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination
Kshitij Srivastava, Kamille A. West, Valeria De Giorgi, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 3
Open Access | Times Cited: 6
Low Levels of Neutralizing Antibodies After Natural Infection With Severe Acute Respiratory Syndrome Coronavirus 2 in a Community-Based Serological Study
Thomas W. McDade, Amelia Sancilio, Richard T. D’Aquila, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 3
Open Access | Times Cited: 4
Donor selection for adoptive cell therapy with CD45RA− memory T cells for patients with coronavirus disease 2019, and dexamethasone and interleukin-15 effects on the phenotype, proliferation and interferon gamma release
Karima Al‐Akioui‐Sanz, B. Pascual-Miguel, Mariana Díaz‐Almirón, et al.
Cytotherapy (2022) Vol. 25, Iss. 3, pp. 330-340
Open Access | Times Cited: 4
Benefits of near-universal vaccination and treatment access to manage COVID-19 burden in the United States
Fuhan Yang, Thu Nguyen-Anh Tran, Emily Howerton, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Durability of SARS-CoV-2-specific T cell responses at 12-months post-infection
Zhongyan Lu, Eric D. Laing, Jarina Pena-Damata, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 4
Regulatory challenges of convalescent plasma collection during the evolving stages of COVID‐19 pandemic in the United States
Sajjad Hassan, Kamille A. West, Kathleen Conry‐Cantilena, et al.
Transfusion (2021) Vol. 62, Iss. 2, pp. 483-492
Open Access | Times Cited: 4
Descriptive evaluation of antibody responses to severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in plasma and gingival crevicular fluid in a nursing home cohort—Arkansas, June–August 2020
Nicole Brown, Amanda K. Lyons, Amy J. Schuh, et al.
Infection Control and Hospital Epidemiology (2021) Vol. 43, Iss. 11, pp. 1610-1617
Open Access | Times Cited: 4
Palaeoserology – teeth put into ancient plagues and pandemics
Kai Dallmeier
Microbial Biotechnology (2022) Vol. 15, Iss. 7, pp. 1940-1942
Open Access | Times Cited: 3
The Benefits and Costs of U.S. Employer COVID-19 Vaccine Mandates
Maddalena Ferranna, Lisa J. Robinson, Daniel Cadarette, et al.
(2022)
Open Access | Times Cited: 3
Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study
Faisal Alasmari, Mahmoud Mukahal, Alaa Ashraf Alqurashi, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0272818-e0272818
Open Access | Times Cited: 3
Progress of the COVID-19: Persistence, Effectiveness, and Immune Escape of the Neutralizing Antibody in Convalescent Serum
Dan Liang, Guanting Zhang, Mingxing Huang, et al.
Pathogens (2022) Vol. 11, Iss. 12, pp. 1531-1531
Open Access | Times Cited: 3
Longitudinal Qualitative and Quantitative Evaluation of SARS-CoV-2 Antibodies in Immunized Health Care Workers
Ellie Hong, Chike C. Nwabuo, Angelina King, et al.
Archives of Pathology & Laboratory Medicine (2023)
Open Access | Times Cited: 1
Factors Associated with SARS-CoV-2 Infection Evaluated by Antibody Response in a Sample of Workers from the Emilia-Romagna Region, Northern Italy
Stefania Paduano, Michele Granata, Sara Turchi, et al.
Antibodies (2023) Vol. 12, Iss. 4, pp. 77-77
Open Access | Times Cited: 1
A retrospective study suggests 55 days of persistence of SARS-CoV-2 during the first wave of the pandemic in Santiago de Chile
Claudio Acuña‐Castillo, Mabel Vidal, Eva Vallejos‐Vidal, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e24419-e24419
Open Access
Relationship of various COVID-19 antibody titer with individual characteristics and prediction of future epidemic trend in Xiamen City, China
L.Z. Liu S.L. Yang G.Q. Xu, Buasiyamu Abudunaibi, Zhiqi Zeng, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 4, pp. 2404-2420
Open Access
Estimation of Total Immunity to SARS-CoV-2 in Texas
Stacia M. DeSantis, Luis León‐Novelo, Michael D. Swartz, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Ultra-Fast and Sensitive Screening for Antibodies against the SARS-CoV-2 S1 Spike Antigen with a Portable Bioelectric Biosensor
Sophie Mavrikou, George Marios Papaioannou, Vasileios Tsekouras, et al.
Chemosensors (2022) Vol. 10, Iss. 7, pp. 254-254
Open Access | Times Cited: 2
Dynamic changes in the concentration of anti-SARS-CoV-2 antibodies within 12 months after recovery from COVID-19
Nikolay Mayanskiy, EA Brzhozovskaya, SS Stoyanova, et al.
Bulletin of Russian State Medical University (2022), Iss. 2022(1)
Open Access | Times Cited: 1
Dinamika koncentracii antitel k SARS-CoV-2 v techenie 12 mesyacev posle perenesennoj infekcii COVID-19
Н. А. Маянский, Е. А. Бржозовская, С. С. Стоянова, et al.
Вестник Российского государственного медицинского университета (2022), Iss. 2022(1)
Open Access | Times Cited: 1

Scroll to top